cosyntropin and Pain

cosyntropin has been researched along with Pain* in 2 studies

Other Studies

2 other study(ies) available for cosyntropin and Pain

Article	Year
[Effects of delayed-action tetracosactide on chronic pain]. Presse medicale (Paris, France : 1983), 1988, Feb-13, Volume: 17, Issue:5 Beta 1-24 corticotrophin was the object of an open trial in the "acute" treatment of chronic pain in 22 patients. The analgesic effect of the drug was assessed before and after two weeks of treatment by means of 3 subjective tests: visual analogue scale, numeric scale and Mac Gill pain questionnaire. The results were statistically significant (P less than 0.01). They confirmed that slow-release tetracosactide exerts a beneficial effect on the sensory-discriminative and affective-emotional components of pain. The drug may be prescribed for short periods (1 to 2 weeks) to patients with chronic pain refractory to the usual treatments. Its analgesic effect is immediate and enables a conventional treatment to be instituted. Topics: Chronic Disease; Cosyntropin; Delayed-Action Preparations; Drug Evaluation; Humans; Middle Aged; Pain; Pain Measurement	1988
[Analgesic action of tetracosactide in chronic pain syndromes]. La Clinica terapeutica, 1981, Sep-30, Volume: 98, Issue:6 Topics: Adrenocorticotropic Hormone; Chronic Disease; Cicatrix; Cosyntropin; Fibromyalgia; Headache; Humans; Neoplasms; Neuralgia; Pain; Palliative Care	1981

Article

Year

[Effects of delayed-action tetracosactide on chronic pain].

Presse medicale (Paris, France : 1983), 1988, Feb-13, Volume: 17, Issue:5

Beta 1-24 corticotrophin was the object of an open trial in the "acute" treatment of chronic pain in 22 patients. The analgesic effect of the drug was assessed before and after two weeks of treatment by means of 3 subjective tests: visual analogue scale, numeric scale and Mac Gill pain questionnaire. The results were statistically significant (P less than 0.01). They confirmed that slow-release tetracosactide exerts a beneficial effect on the sensory-discriminative and affective-emotional components of pain. The drug may be prescribed for short periods (1 to 2 weeks) to patients with chronic pain refractory to the usual treatments. Its analgesic effect is immediate and enables a conventional treatment to be instituted.

Topics: Chronic Disease; Cosyntropin; Delayed-Action Preparations; Drug Evaluation; Humans; Middle Aged; Pain; Pain Measurement

1988

[Analgesic action of tetracosactide in chronic pain syndromes].

La Clinica terapeutica, 1981, Sep-30, Volume: 98, Issue:6

Topics: Adrenocorticotropic Hormone; Chronic Disease; Cicatrix; Cosyntropin; Fibromyalgia; Headache; Humans; Neoplasms; Neuralgia; Pain; Palliative Care

1981